DV
Dividend Vision

PACB — Pacific Biosciences of California

Pacific Biosciences of California (PACB)

Total return is -93.0% over the past 15.8 years, 859.4 points behind SPY at 766.4%. Its deepest 1-year drawdown was 58.4%.

PACB is a single-stock equity holding that tracks Pacific Biosciences of California, a life sciences company focused on DNA sequencing technology. The stock does not currently pay dividends, making it unsuitable for income-focused strategies. This holding appeals primarily to growth-oriented investors seeking exposure to the biotechnology and genomics sector rather than dividend investors.

PACB key facts

Asset type
Stock
Asset class
Equity
Inception date
10/27/2010
Last close
$1.15
Market cap
$422,418,304
Average volume
3933000.0
Beta
2.289
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.39